skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 31  for All Library Resources

Results 1 2 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Pathologist at the doorstep of cancer “I know your weaknesses and strength”: an interview with Jean Claude Reubi
Material Type:
Article
Add to My Research

Pathologist at the doorstep of cancer “I know your weaknesses and strength”: an interview with Jean Claude Reubi

European journal of nuclear medicine and molecular imaging, 2020-04, Vol.47 (4), p.741-743 [Peer Reviewed Journal]

Springer-Verlag GmbH Germany, part of Springer Nature 2020 ;European Journal of Nuclear Medicine and Molecular Imaging is a copyright of Springer, (2020). All Rights Reserved. ;ISSN: 1619-7070 ;EISSN: 1619-7089 ;DOI: 10.1007/s00259-020-04679-0 ;PMID: 32020369

Full text available

2
Prognostic Significance of Somatostatin Receptor Heterogeneity in Progressive Neuroendocrine Tumor Treated with Lu-177 DOTATOC or Lu-177 DOTATATE
Material Type:
Article
Add to My Research

Prognostic Significance of Somatostatin Receptor Heterogeneity in Progressive Neuroendocrine Tumor Treated with Lu-177 DOTATOC or Lu-177 DOTATATE

European journal of nuclear medicine and molecular imaging, 2020-04, Vol.47 (4), p.881-894 [Peer Reviewed Journal]

Springer-Verlag GmbH Germany, part of Springer Nature 2019 ;European Journal of Nuclear Medicine and Molecular Imaging is a copyright of Springer, (2019). All Rights Reserved. ;ISSN: 1619-7070 ;EISSN: 1619-7089 ;DOI: 10.1007/s00259-019-04439-9 ;PMID: 31414209

Full text available

3
Lessons from a multicentre retrospective study of peptide receptor radionuclide therapy combined with lanreotide for neuroendocrine tumours: a need for standardised practice
Material Type:
Article
Add to My Research

Lessons from a multicentre retrospective study of peptide receptor radionuclide therapy combined with lanreotide for neuroendocrine tumours: a need for standardised practice

European journal of nuclear medicine and molecular imaging, 2020-09, Vol.47 (10), p.2358-2371 [Peer Reviewed Journal]

The Author(s) 2020 ;The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1619-7070 ;EISSN: 1619-7089 ;DOI: 10.1007/s00259-020-04712-2 ;PMID: 32062681

Full text available

4
Interobserver variability, detection rate, and lesion patterns of 68Ga-PSMA-11-PET/CT in early-stage biochemical recurrence of prostate cancer after radical prostatectomy
Material Type:
Article
Add to My Research

Interobserver variability, detection rate, and lesion patterns of 68Ga-PSMA-11-PET/CT in early-stage biochemical recurrence of prostate cancer after radical prostatectomy

European journal of nuclear medicine and molecular imaging, 2020-09, Vol.47 (10), p.2339-2347 [Peer Reviewed Journal]

The Author(s) 2020 ;The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1619-7070 ;EISSN: 1619-7089 ;DOI: 10.1007/s00259-020-04718-w ;PMID: 32157427

Full text available

5
Why wait for posterity (or the future) to provide proof to savor the elixir of precision oncology? Read interviews with intellects and dine with the doyens of discovery
Material Type:
Article
Add to My Research

Why wait for posterity (or the future) to provide proof to savor the elixir of precision oncology? Read interviews with intellects and dine with the doyens of discovery

European journal of nuclear medicine and molecular imaging, 2019-11, Vol.46 (12), p.2418-2420 [Peer Reviewed Journal]

Springer-Verlag GmbH Germany, part of Springer Nature 2019 ;European Journal of Nuclear Medicine and Molecular Imaging is a copyright of Springer, (2019). All Rights Reserved. ;ISSN: 1619-7070 ;EISSN: 1619-7089 ;DOI: 10.1007/s00259-019-04484-4 ;PMID: 31435715

Full text available

6
Detection of unknown primary neuroendocrine tumours (CUP-NET) using (68)Ga-DOTA-NOC receptor PET/CT
Material Type:
Article
Add to My Research

Detection of unknown primary neuroendocrine tumours (CUP-NET) using (68)Ga-DOTA-NOC receptor PET/CT

European journal of nuclear medicine and molecular imaging, 2010-01, Vol.37 (1), p.67-77 [Peer Reviewed Journal]

EISSN: 1619-7089 ;DOI: 10.1007/s00259-009-1205-y ;PMID: 19618183

Full text available

7
Potential role of (68)Ga-DOTATOC PET/CT in screening for pancreatic neuroendocrine tumour in patients with von Hippel-Lindau disease
Material Type:
Article
Add to My Research

Potential role of (68)Ga-DOTATOC PET/CT in screening for pancreatic neuroendocrine tumour in patients with von Hippel-Lindau disease

European journal of nuclear medicine and molecular imaging, 2016-10, Vol.43 (11), p.2014-2020 [Peer Reviewed Journal]

EISSN: 1619-7089 ;DOI: 10.1007/s00259-016-3421-6 ;PMID: 27293206

Full text available

8
Potential role of 68Ga-DOTATOC PET/CT in screening for pancreatic neuroendocrine tumour in patients with von Hippel-Lindau disease
Material Type:
Article
Add to My Research

Potential role of 68Ga-DOTATOC PET/CT in screening for pancreatic neuroendocrine tumour in patients with von Hippel-Lindau disease

European journal of nuclear medicine and molecular imaging, 2016-10, Vol.43 (11), p.2014-2020 [Peer Reviewed Journal]

Springer-Verlag Berlin Heidelberg 2016 ;European Journal of Nuclear Medicine and Molecular Imaging is a copyright of Springer, (2016). All Rights Reserved. ;ISSN: 1619-7070 ;EISSN: 1619-7089 ;DOI: 10.1007/s00259-016-3421-6

Full text available

9
Role of (68)Ga somatostatin receptor PET/CT in the detection of endogenous hyperinsulinaemic focus: an explorative study
Material Type:
Article
Add to My Research

Role of (68)Ga somatostatin receptor PET/CT in the detection of endogenous hyperinsulinaemic focus: an explorative study

European journal of nuclear medicine and molecular imaging, 2016-08, Vol.43 (9), p.1593-1600 [Peer Reviewed Journal]

EISSN: 1619-7089 ;DOI: 10.1007/s00259-016-3331-7 ;PMID: 26923247

Full text available

10
How smart is peptide receptor radionuclide therapy of neuroendocrine tumors especially in the salvage setting? The clinician’s perspective
Material Type:
Article
Add to My Research

How smart is peptide receptor radionuclide therapy of neuroendocrine tumors especially in the salvage setting? The clinician’s perspective

European journal of nuclear medicine and molecular imaging, 2014-02, Vol.41 (2), p.202-204 [Peer Reviewed Journal]

Springer-Verlag Berlin Heidelberg 2013 ;Springer-Verlag Berlin Heidelberg 2014 ;ISSN: 1619-7070 ;EISSN: 1619-7089 ;DOI: 10.1007/s00259-013-2593-6 ;PMID: 24196915

Full text available

11
PET/CT imaging of osteoblastic bone metastases with (68)Ga-bisphosphonates: first human study
Material Type:
Article
Add to My Research

PET/CT imaging of osteoblastic bone metastases with (68)Ga-bisphosphonates: first human study

European journal of nuclear medicine and molecular imaging, 2010-04, Vol.37 (4), p.834 [Peer Reviewed Journal]

EISSN: 1619-7089 ;DOI: 10.1007/s00259-009-1355-y ;PMID: 20069291

Full text available

12
Whither peptide receptor radionuclide therapy for neuroendocrine tumors: an Einsteinian view of the facts and myths
Material Type:
Article
Add to My Research

Whither peptide receptor radionuclide therapy for neuroendocrine tumors: an Einsteinian view of the facts and myths

European journal of nuclear medicine and molecular imaging, 2014-10, Vol.41 (10), p.1825-1830 [Peer Reviewed Journal]

Springer-Verlag Berlin Heidelberg 2014 ;ISSN: 1619-7070 ;EISSN: 1619-7089 ;DOI: 10.1007/s00259-014-2780-0 ;PMID: 24806111

Full text available

13
The future of nuclear medicine imaging of neuroendocrine tumors: on a clear day one might see forever
Material Type:
Article
Add to My Research

The future of nuclear medicine imaging of neuroendocrine tumors: on a clear day one might see forever

European journal of nuclear medicine and molecular imaging, 2014-12, Vol.41 (12), p.2189-2193 [Peer Reviewed Journal]

Springer-Verlag Berlin Heidelberg 2014 ;ISSN: 1619-7070 ;EISSN: 1619-7089 ;DOI: 10.1007/s00259-014-2836-1 ;PMID: 25047018

Full text available

14
Role of 68Ga somatostatin receptor PET/CT in the detection of endogenous hyperinsulinaemic focus: an explorative study
Material Type:
Article
Add to My Research

Role of 68Ga somatostatin receptor PET/CT in the detection of endogenous hyperinsulinaemic focus: an explorative study

European journal of nuclear medicine and molecular imaging, 2016-08, Vol.43 (9), p.1593-1600 [Peer Reviewed Journal]

Springer-Verlag Berlin Heidelberg 2016 ;ISSN: 1619-7070 ;EISSN: 1619-7089 ;DOI: 10.1007/s00259-016-3331-7

Full text available

15
Role of ^sup 68^Ga somatostatin receptor PET/CT in the detection of endogenous hyperinsulinaemic focus: an explorative study
Material Type:
Article
Add to My Research

Role of ^sup 68^Ga somatostatin receptor PET/CT in the detection of endogenous hyperinsulinaemic focus: an explorative study

European journal of nuclear medicine and molecular imaging, 2016-08, Vol.43 (9), p.1593 [Peer Reviewed Journal]

Springer-Verlag Berlin Heidelberg 2016 ;ISSN: 1619-7070 ;EISSN: 1619-7089 ;DOI: 10.1007/s00259-016-3331-7

Full text available

16
Role of super(68)Ga somatostatin receptor PET/CT in the detection of endogenous hyperinsulinaemic focus: an explorative study
Material Type:
Article
Add to My Research

Role of super(68)Ga somatostatin receptor PET/CT in the detection of endogenous hyperinsulinaemic focus: an explorative study

European journal of nuclear medicine and molecular imaging, 2016-08, Vol.43 (9), p.1593-1600 [Peer Reviewed Journal]

ISSN: 1619-7070 ;EISSN: 1619-7089 ;DOI: 10.1007/s00259-016-3331-7

Full text available

17
Interobserver variability, detection rate, and lesion patterns of 68 Ga-PSMA-11-PET/CT in early-stage biochemical recurrence of prostate cancer after radical prostatectomy
Material Type:
Article
Add to My Research

Interobserver variability, detection rate, and lesion patterns of 68 Ga-PSMA-11-PET/CT in early-stage biochemical recurrence of prostate cancer after radical prostatectomy

European journal of nuclear medicine and molecular imaging, 2020-09, Vol.47 (10), p.2339 [Peer Reviewed Journal]

EISSN: 1619-7089 ;PMID: 32157427

Full text available

18
Reply: Diagnosis of neuroendocrine tumours and the costs for different tracers – the real problem behind the scenes
Material Type:
Article
Add to My Research

Reply: Diagnosis of neuroendocrine tumours and the costs for different tracers – the real problem behind the scenes

European journal of nuclear medicine and molecular imaging, 2012-04, Vol.39 (4), p.725-726 [Peer Reviewed Journal]

Springer-Verlag 2012 ;ISSN: 1619-7070 ;EISSN: 1619-7089 ;DOI: 10.1007/s00259-011-2011-x

Full text available

19
Comparison of sequential planar ^sup 177^Lu-DOTA-TATE dosimetry scans with ^sup 68^Ga-DOTA-TATE PET/CT images in patients with metastasized neuroendocrine tumours undergoing peptide receptor radionuclide therapy
Material Type:
Article
Add to My Research

Comparison of sequential planar ^sup 177^Lu-DOTA-TATE dosimetry scans with ^sup 68^Ga-DOTA-TATE PET/CT images in patients with metastasized neuroendocrine tumours undergoing peptide receptor radionuclide therapy

European journal of nuclear medicine and molecular imaging, 2012-03, Vol.39 (3), p.501 [Peer Reviewed Journal]

Springer-Verlag 2012 ;ISSN: 1619-7070 ;EISSN: 1619-7089 ;DOI: 10.1007/s00259-011-2003-x

Full text available

20
Comparison of sequential planar super(177)Lu-DOTA-TATE dosimetry scans with super(68)Ga-DOTA-TATE PET/CT images in patients with metastasized neuroendocrine tumours undergoing peptide receptor radionuclide therapy
Material Type:
Article
Add to My Research

Comparison of sequential planar super(177)Lu-DOTA-TATE dosimetry scans with super(68)Ga-DOTA-TATE PET/CT images in patients with metastasized neuroendocrine tumours undergoing peptide receptor radionuclide therapy

European journal of nuclear medicine and molecular imaging, 2012-03, Vol.39 (3), p.501-511 [Peer Reviewed Journal]

ISSN: 1619-7070 ;EISSN: 1619-7089 ;DOI: 10.1007/s00259-011-2003-x

Full text available

Results 1 - 20 of 31  for All Library Resources

Results 1 2 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 2010  (1)
  2. 2010 To 2010  (6)
  3. 2011 To 2011  (3)
  4. 2012 To 2014  (10)
  5. After 2014  (12)
  6. More options open sub menu

Searching Remote Databases, Please Wait